Détails du rapport Vaer
Âge: N/A
Genre: Male
Région : Outside US
- Patient décédé?
- Non
- Renseignements sur les vaccins
-
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
Fabricant: PFIZER
Lot: unknown
- Date de réception du rapport
- 2022-03-04
- Date à laquelle le formulaire est complèté
- Date de vaccination
- Date d’apparition
- 0
- Nombre de jours (date d’apparition – date de vaccination)
- 0
- Description de l’événement indésirable
-
symptomatic sars cov 2 infection in a booster subject; symptomatic sars cov 2 infection in a booster subject; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp). the reporter is the patient. a 76 year-old male patient received bnt162b2 (comirnaty) (batch/lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "diabetes" (unspecified if ongoing), notes: in good multidrug control. the patient's concomitant medications were not reported. vaccination history included: comirnaty (dose 1, single), for covid-19 immunization; comirnaty (dose 2, single), for covid-19 immunization. the following information was reported: suspected covid-19 (medically significant), drug ineffective (medically significant), outcome "recovering" and all described as "symptomatic sars cov 2 infection in a booster subject. the lot number for bnt162b2 was not provided and will be requested during follow up. clinical course: symptoms: cold sore hoarseness, not fever, in apparent rapid resolution
- Données de laboratoire
-
na
- Liste des symptômes
-
drug ineffective suspected covid-19
- Patient décédé?
- Non
- Date de décès
- N/A
- Anomalie congénitale
- false
- Vaccin administré par :
- Other
- Vaccin acheté par :
- Inconnu
- Visite d’un patient à l’urgence?
- Non
- Patient hospitalisé?
- Non
- Séjour à l’hôpital
- Non
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Non
- Allergies:
-
na
- Maladie actuelle
-
na